article thumbnail

We’re at a Turning Point for Alzheimer’s Disease Research

MedCity News

Medical science has made significant strides in the development of advanced treatments over the past decade. However, the majority of FDA-approved treatments for Alzheimer’s focus on the management of symptoms or delayed progression of the disease.

article thumbnail

How AI Can Help Medical Science Liaisons Juggle Their Ever-Growing Responsibilities

PM360

Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. 1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novaliq’s dry eye disease therapy receives US FDA approval

Pharmaceutical Technology

Biopharmaceutical company Novaliq has received approval from the US Food and Drug Administration (FDA) for VEVYE (cyclosporine ophthalmic solution) 0.1% Novaliq medical science and regulatory affairs vice-president Sonja Krösser stated: “We are proud that the FDA approved VEVYE.

article thumbnail

Progressing personalised cell therapies in oncology

European Pharmaceutical Review

Last month, CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) was the first BCMA-targeted CAR-T cell therapy to be approved for second-line treatment of multiple myeloma by the US Food and Drug Administration (FDA). Most recently, Imran has served as Medical Science Liaison (MSL) Head, Oncology U.S. Medical Affairs.

article thumbnail

Reducing real world data lag time for improved patient outcomes

Clarivate

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. The suitability of RWD, the FDA said in a 2017 guidance report , depends on its relevance (whether data directly addresses intended use) and reliability (completeness, accuracy and timeliness) [2].

article thumbnail

Pharmaceutical Companies Also Made the Fortune 500 List

Medico Reach

It developed the COVID vaccine Comirnaty and received FDA approval for TicoVac and Prevnar 20. They received FDA approval for emergency usage of REGEN-COV, their proprietary vaccine. twitter.com/pfizer | : linkedin.com/company/pfizer/ . Invention ranking : 13. Innovation ranking : 3. Industry revenue : $16.1 CEO : Leonard Schleifer.

article thumbnail

Manufacturing challenges set back development progress of cell therapies in oncology

Pharmaceutical Technology

Last year, lifileucel was previously plagued by a different delay, which was an inability to convince the US Food and Drug Administration (FDA) that its potency assays for TILs were robust enough to lead to a uniform product.